Fractionation Fundamentals - Dose Delivery Dance
- Definition: Dividing total radiotherapy dose into multiple smaller, daily fractions over weeks.
- Aim: Enhance therapeutic ratio: maximize tumor damage, minimize normal tissue injury.
- The 4 R's of Radiobiology:
- Repair: Normal tissues repair sublethal damage (SLD) more efficiently.
- Reoxygenation: Hypoxic tumor regions gain O₂, ↑ radiosensitivity.
- Redistribution: Cells enter radiosensitive cell cycle phases (G2/M).
- Repopulation: Normal cells regenerate; tumor cells too if overall treatment time is protracted.
- Standard: 1.8-2 Gy/fraction, daily, 5x/week.
⭐ Fractionation primarily exploits differential repair in normal tissues and reoxygenation in tumors, improving therapeutic outcomes.
The 5 R's of Radiobiology - Cell Survival Saga
The biological basis for fractionation's success. 📌 Key principles:
- Repair: Normal tissues repair Sublethal Damage (SLD) more efficiently than tumors between fractions. Allows normal tissue sparing.
- Repopulation: Surviving normal and tumor cells divide between fractions. Can be detrimental if tumor repopulation is fast; prolonging treatment time can ↓ local control.
- Reoxygenation: Hypoxic (radioresistant) tumor core cells gain oxygen access as outer cells die, becoming more radiosensitive.
- Redistribution (Reassortment): Surviving cells progress through the cell cycle. Fractionation catches more cells in sensitive phases (G2/M).
- Radiosensitivity: Intrinsic differences in radiation sensitivity among cells and tumor types. Fractionation exploits these differences.
⭐ Reoxygenation is critical: hypoxic cells can be 2-3 times more radioresistant than normoxic cells. Fractionation helps overcome this tumor radioresistance mechanism.
Scheduling Strategies - Time-Dose Tactics
Fractionation exploits differences in repair capacity (one of the 5 R's) between tumor and normal tissues. Based on Linear-Quadratic (LQ) model: $E = n(\alpha d + \beta d^2)$. Biologically Effective Dose (BED) = $D(1 + d/(\alpha/\beta))$ helps compare schedules.
- α/β ratio: Tumors ≈ 10 Gy (early effects); Late-responding tissues ≈ 3 Gy.
| Schedule | Dose/Fx (Gy) | Fx/Day | Overall Time | Total Dose | Rationale/Impact |
|---|---|---|---|---|---|
| Conventional (CF) | 1.8-2.0 | 1 | 6-7 wks | Standard | Standard; Balanced efficacy & toxicity. |
| Hyperfractionation (HF) | 1.1-1.2 (↓) | 2-3 | Similar | ↑ | ↓ Late toxicity (spares low α/β tissues); ≥6h interval. |
| Accelerated (AF) | Standard/↓ | ≥1 | ↓ (<6 wks) | Similar/↓ | ↓ Repopulation in fast tumors; ↑ Acute toxicity. |
| Hypofractionation (HypoF) | >2.5 (↑) | 1 | ↓ | ↓ | Low α/β tumors (e.g., prostate); Palliative; ↑ Late effects risk. |
| CHART | 1.5 | 3 | 12 days | 54 Gy | Continuous (no weekend break); ↓ Repopulation; ↑ Acute mucosal tox. |
LQ Model & BED - Radiobiologic Math
- Linear-Quadratic (LQ) Model: Predicts cell kill from radiation.
- Total biological effect: $E = n(\alpha d + \beta d^2)$.
- $n$: number of fractions, $d$: dose/fraction.
- $\alpha$ component: irreparable DNA damage (linear cell kill).
- $\beta$ component: repairable/misrepaired DNA damage (quadratic cell kill).
- $\alpha/\beta$ ratio: Measures fractionation sensitivity.
- Tumors & acute effects: ~10 Gy (less sensitive to changes in $d$).
- Late effects: ~3 Gy (more sensitive to changes in $d$; sparing with lower $d$).
- Total biological effect: $E = n(\alpha d + \beta d^2)$.
- Biologically Effective Dose (BED): Total biological impact of a radiotherapy schedule.
- Formula: $BED = D(1 + d/(\alpha/\beta))$.
- $D$: total physical dose ($nd$).
- Allows isoeffective dose calculations for different fractionation regimens.
⭐ For late-responding tissues (low $\alpha/\beta$), BED increases significantly with larger fraction sizes ($d$), potentially increasing late toxicity.

- Formula: $BED = D(1 + d/(\alpha/\beta))$.
High‑Yield Points - ⚡ Biggest Takeaways
- Fractionation improves therapeutic ratio by exploiting the 4 R's: Repair, Repopulation, Reoxygenation, Redistribution.
- BED compares schedules using total dose, dose/fraction, and α/β ratio.
- Late-responding tissues have low α/β ratios (e.g., ~3 Gy), spared by smaller fractions.
- Tumors & early-responding tissues usually have high α/β ratios (e.g., ~10 Gy).
- Hyperfractionation (smaller dose/fraction) aims to ↓ late toxicity.
- Hypofractionation (larger dose/fraction) for palliative care or specific tumors_._
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app